Populations appropriate for diabetes screening with retesting every 3 years
The USPSTF recommends diabetes screening as part of a cardiovascular risk assessment in asymptomatic adults who are overweight or obese and aged between 40 and 70.
©6okean - stock.adobe.com
Patients with pyelonephritis
Aymptomatic people with BMI > 25 kg/m2 (23 kg/m2 if Asian-American)
Age > 45
Children or adolescents with BMI > 85th centile or with additional risk factors
High-risk racial-ethnic background
First-degree relative with T2DM
History of GDM
PCOS
TGs > 250 ml/dL or HDL cholesterol < 35 mg/dL
History of CVD
Inactivity, severe obesity (BMI > 35 kg/m2), acanthosis nigricans
IGT, IFG or prediabetes: restest annualy
BMI = body mass index; CVD = cardiovascular disease; GDM = gestational diabetes; HDL = high-density lipoprotein; IGT = impaired glucose tolerance; IFG = impaired fasting glucose; PCOS = polycystic ovary syndrome; TG = triglycerides; T2DM = type 2 diabetes mellitus
The US Preventive Services Task Force recommends diabetes screening as part of a cardiovascular risk assessment in asymptomatic adults who are overweight or obese and aged between 40 and 70. Individuals with a history of PCOS< GDM, and those of higher-risk racial and ethnic groups should be considered for screening at younger ages and lower body mass indexes.
Read more: Type 2 diabetes in the non-pregnant patient
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More
